Takeda Pharmaceutical Co (TSE:4502) Float Percentage Of Total Shares Outstanding: 99.93% (As of Jul. 07, 2026)


TSE:4502 Takeda Pharmaceutical Co Ltd TSE:4502
64 GF Score
Price 円5,448.00
GF Value 円4,535.49
Valuation Modestly Overvalued
! 10 Warning Signs
View Full Analysis

What is Takeda Pharmaceutical Co Float Percentage Of Total Shares Outstanding?

Takeda Pharmaceutical Co TSE:4502 -1.25% 64 Float Percentage Of Total Shares Outstanding is 99.93% as of Jul. 07, 2026. GuruFocus rates TSE:4502 with a GF Score™ of 64/100 and a GF Value™ of 円4,535.49 (Modestly Overvalued). The stock has 10 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Takeda Pharmaceutical Co's float shares is 1,578.69 Mil. Takeda Pharmaceutical Co's total shares outstanding is 1,579.87 Mil. Takeda Pharmaceutical Co's float percentage of total shares outstanding is 99.93%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Takeda Pharmaceutical Co's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Takeda Pharmaceutical Co's Institutional Ownership is 42.63%.

TSE:4502
64GF Score
Takeda Pharmaceutical Co Ltd TSE:4502
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Takeda Pharmaceutical Co Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Takeda Pharmaceutical Co's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=1,578.69/1,579.87
=99.93%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 99.93% mean?
Takeda Pharmaceutical Co (TSE:4502) has a Float Percentage Of Total Shares Outstanding of 99.93% as of Jul. 07, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Takeda Pharmaceutical Co and its competitors.
Is Takeda Pharmaceutical Co's Float Percentage Of Total Shares Outstanding too high?
Takeda Pharmaceutical Co's current Float Percentage Of Total Shares Outstanding is 99.93%. Overall, Takeda Pharmaceutical Co has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Takeda Pharmaceutical Co's Float Percentage Of Total Shares Outstanding compare to ZTS and UTHR?
Takeda Pharmaceutical Co's Float Percentage Of Total Shares Outstanding of 99.93% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Drug Manufacturers company?
A good Float Percentage Of Total Shares Outstanding depends on the Drug Manufacturers industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Takeda Pharmaceutical Co and its competitors. Takeda Pharmaceutical Co's current Float Percentage Of Total Shares Outstanding is 99.93%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Takeda Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Takeda Pharmaceutical Co (TSE:4502) is currently considered Modestly Overvalued. The stock's GF Value™ is 円4,535.49, compared to a current price of 円5,448.00 — trading 20.1% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 99.93%. Takeda Pharmaceutical Co's overall GF Score™ is 64/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Takeda Pharmaceutical Co (TSE:4502), the current Float Percentage Of Total Shares Outstanding is 99.93% as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Takeda Pharmaceutical Co (TSE:4502) Overvalued in 2026?

Based on GuruFocus' analysis, Takeda Pharmaceutical Co stock appears to be overvalued. The current stock price of 円5,448.00 is trading 20.1% above its estimated GF Value™ of 円4,535.49. GuruFocus considers Takeda Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for TSE:4502:

  • Float Percentage Of Total Shares Outstanding: 99.93%
  • GF Value™: 円4,535.49 vs. price of 円5,448.00 (20.1% above fair value)
  • GF Score™: 64/100 with 10 warning signs

No single metric tells the full story. See the TSE:4502 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Takeda Pharmaceutical Co Business Description

Address 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
64GF Score

Get the complete analysis for TSE:4502

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円5,448.00
Price
円4,535.49
GF Value